Sorkhi Hadi, Saeedizand Nazanin, Poornasrollah Mohammad, Bijani Ali, Shafi Hamid
Non-Communicable Pediatric Diseases Research Center, Health Research Institute, Babol University of Medical Sciences, Babol.
Student Research Committee, Babol University of Medical Sciences, Babol, Iran.
Caspian J Intern Med. 2017 Fall;8(4):296-300. doi: 10.22088/cjim.8.4.296.
According to high prevalence of renal stone in children, we evaluated the efficacy of treatment with potassium citrate and its correlation with metabolic disorders in children less than two years of age with renal stone and microlithiasis.
In this cross- sectionaly study, 100 patients (less than 2 years old) with renal stone or microlitiasis were evaluated for metabolic disorders. They were treated with potassium citrate and followed-up by ultrasonography every 3 months. Then response to treatment was evaluated according to the fresence metabolic disorders (A p-alue<0.05 was significant).
According to this study, hyperuricosuria and hypercalciuria were the two major metabolic disorders (40-33%). Seventy three patients had complete response, and also there as not a significant difference (p<0.05) in the efficacy of treatment due to types of metabolic disorders. There was significant difference between relative response to treatment in children who had metabolic disorders and patient without any metabolic disorders.
Based on our results the use of potassium citrate in all children less than 2 years with renal stone or microlithiasis especially those with metabolic disorders, are recommended.
鉴于儿童肾结石的高发病率,我们评估了枸橼酸钾治疗2岁以下肾结石及微结石症患儿的疗效及其与代谢紊乱的相关性。
在这项横断面研究中,对100例(2岁以下)肾结石或微结石症患儿进行代谢紊乱评估。他们接受枸橼酸钾治疗,并每3个月通过超声进行随访。然后根据是否存在代谢紊乱评估治疗反应(P值<0.05具有显著性)。
根据本研究,高尿酸尿症和高钙尿症是两种主要的代谢紊乱(分别为40% - 33%)。73例患者有完全反应,且由于代谢紊乱类型不同,治疗效果无显著差异(P<0.05)。有代谢紊乱的儿童与无任何代谢紊乱的患者在治疗相对反应方面存在显著差异。
基于我们的结果,建议对所有2岁以下肾结石或微结石症患儿,尤其是那些有代谢紊乱的患儿使用枸橼酸钾。